ArriVent BioPharma, Inc. (AVBP) Income Statement

Last quarter (Q3 2024), ArriVent BioPharma, Inc.'s total revenue was $―, a decrease of ― from previous quarter. In Q3, ArriVent BioPharma, Inc.'s net income was $-20.56M. See ArriVent BioPharma, Inc.’s key income statements, including revenue, expenses, profit, and income.